Skip to content

Contact +44 (0) 20 7060 7474 email us

Search Results


The product title you are looking for is no longer available. Other similar products that may interest you are listed below:

Refine your Search

Results for 'Clinical trials in Russia 2008'
Title Publication Date Price Relevance
Clinical Trials Market in Russia
 May 2009 £530 50 %
Global Clinical Trial Business Report & Analysis 2008-2018
 July 2008 £1499 35 %
Russian Pharma Sector Analysis (2007)
 August 2007 £725 31.85 %
Aortic Stent Graft Clinical Trial Analysis
 July 2009 £660 29.05 %
Clinical Trials: World Market 2009-2024
 July 2009 £1499 28 %
Global Protein Therapeutics Market Analysis
 August 2009 £1190 25.2 %
Coronary Stents
Global Market Trends
 November 2009 £1980 23.8 %
Peripheral Vascular Devices Clinical Trial Analysis
 July 2009 £660 23.45 %
Pipeline and Commercial Insight: Osteoporosis
Novel agents to battle for payer acceptance
 July 2009 £10040 22.4 %
Stakeholder Opinions: Tuberculosis - Development pipeline shows signs of life
Healthcare
 March 2009 £1320 21.35 %
Human Vaccines
Global Market Opportunities
 November 2009 £1980 18.9 %
Insulin
Competitor Analysis
 October 2008 £360 18.5 %
Eli Lilly and Company Medical Equipment Company Share Analysis
 September 2008 £660 17.85 %
Hepatitis C Virus and Therapeutics
A Global Update of Market Trends & Opportunities
 November 2009 £1980 17.15 %
Small Molecule Kinase Inhibitors
 July 2009 £2610 17.15 %
Women's Reproductive Disorders Therapeutics 2008-2018
 September 2008 £1499 16.8 %
Pipeline and Commercial Insight: Nicotine Dependence - Chantix issues overshadow vaccine potential
Healthcare
 March 2009 £5285 15.75 %
Cochlear Limited Medical Equipment Company Share Analysis
 September 2008 £660 15.05 %
Economic Analysis for the Russian Healthcare Industry
 February 2010 £295 14.5 %
Antibiotics
Global Trends
 November 2009 £1980 14.35 %
Baxter International Inc. Medical Equipment Company Report
Medical Device Company Analysis Covering key Information Relating to Company Market Share by Sector and Country, Financial, SWOT and Value Chain Analysis
 April 2008 £335 14 %
Commercial Insight: Asthma & COPD
 June 2009 £10040 12.25 %
Diabetes Drug Pipeline
Competitor Analysis
 November 2008 £1075 10 %
Anti-Infectives
 February 2010 £2610 9.8 %
Nanomedicine
 July 2009 £2610 7.35 %